Literature DB >> 27719854

Functional eye movement disorders.

D Kaski1, A M Bronstein2.   

Abstract

Functional (psychogenic) eye movement disorders are perhaps less established in the medical literature than other types of functional movement disorders. Patients may present with ocular symptoms (e.g., blurred vision or oscillopsia) or functional eye movements may be identified during the formal examination of the eyes in patients with other functional disorders. Convergence spasm is the most common functional eye movement disorder, but functional gaze limitation, functional eye oscillations (also termed "voluntary nystagmus"), and functional convergence paralysis may be underreported. This chapter reviews the different types of functional eye movement abnormalities and provides a practical framework for their diagnosis and management.
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  convergence spasm; eye movements; functional; gaze; nystagmus; psychogenic

Mesh:

Year:  2016        PMID: 27719854     DOI: 10.1016/B978-0-12-801772-2.00030-8

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  4 in total

Review 1.  Eye Movement Disorders in Movement Disorders.

Authors:  Panagiotis Kassavetis; Diego Kaski; Tim Anderson; Mark Hallett
Journal:  Mov Disord Clin Pract       Date:  2022-02-16

Review 2.  Management of diplopia.

Authors:  Daniela Adriana Iliescu; Cristina Mihaela Timaru; Nicolae Alexe; Elena Gosav; Algerino De Simone; Mehdi Batras; Cornel Stefan
Journal:  Rom J Ophthalmol       Date:  2017 Jul-Sep

3.  Functional positional eye and eyelid movements.

Authors:  Mohamed Mabrouk Mustafa; Harry Akram; Manuel Oliva-Domínguez; Diego Kaski
Journal:  J Neurol       Date:  2020-07-15       Impact factor: 4.849

4.  Periorbital injections of botulinum toxin a: a novel therapeutic option for convergence spasm in neuropsychiatric disorders.

Authors:  Kristina Hess; Moritz Schmitt; Bettina Wabbels
Journal:  J Neurol       Date:  2021-05-28       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.